Clinical trials in Orebro – page 10

138 clinical trials in Orebro, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Orebro at a glance

138

clinical trials

Research sites1

Quick filters

138 trials in Orebro

Open in trial search

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lutikizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Study on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Tralokinumab
Sponsor:LEO PHARMA A/S

Contact Research Centre

Study on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Investigational

Sweden

Participants:18–64 years
Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
Sponsor:AstraZeneca AB

Contact Research Centre

Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Simvastatin
Sponsor:Karolinska University Hospital

Contact Research Centre

Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Cytarabine
Sponsor:Karolinska University Hospital

Contact Research Centre

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bomedemstat
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Pfizer Inc.

Contact Research Centre

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Registered drug

Sweden

Participants:0–17 years
Sponsor:Region Dalarna

Contact Research Centre

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Region Skane

Contact Research Centre

B-cell small lymphocytic lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Rituximab
Sponsor:BeOne Medicines AG

Contact Research Centre

Study on Acalabrutinib and Venetoclax for Newly Diagnosed Chronic Lymphocytic Leukemia Patients at High Risk of Infection and Early Treatment Needs

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Acalabrutinib
Sponsor:Region Hovedstaden

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Orebro

What the registry says about research in the country

01 Infectious Diseases & Vaccines

Clinical trials focusing on preventive vaccines against Respiratory Syncytial Virus, Human Metapneumovirus, and Herpes Zoster in older adults. Studies evaluate vaccine efficacy, immune response, and safety profiles.

RSV and hMPV Prevention
Herpes Zoster Protection
HPV Infection Control

02 Metabolic Disorders

Research examining treatments for obesity and Type 2 diabetes. Studies evaluate new therapeutic approaches combining medication with lifestyle modifications for weight management.

Weight Management
Diabetes Control
Cardiovascular Risk Management

03 Oncology

Innovative trials in chronic lymphocytic leukemia, breast cancer, and other malignancies. Studies explore novel treatment combinations and personalized approaches for better patient outcomes.

Leukemia Treatment
Breast Cancer Therapy
Cancer-related Depression

Back to Sweden All countries

Clinical trials in Orebro – page 10

138 trials in Orebro

Hidradenitis

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Dermatitis atopic

Study on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy

Asthma

Study on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Cholangitis sclerosing

Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

Acute myeloid leukaemia

Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

Essential thrombocythaemia

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Plasma cell myeloma

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Dermatitis atopic

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Facial paresis

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Breast cancer

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

B-cell small lymphocytic lymphoma

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic lymphocytic leukaemia

Study on Acalabrutinib and Venetoclax for Newly Diagnosed Chronic Lymphocytic Leukemia Patients at High Risk of Infection and Early Treatment Needs

Filter the trials

Other cities in Sweden

Clinical research in Orebro

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Orebro – page 10

138 trials in Orebro

Other cities in Sweden

Related

Clinical research in Orebro

Prefer not to search? Our Concierge searches the trials for you.